The more we know about our visitors, the easier it will be for us to publish everything you want to see.

Keep me logged in Forgot your password?

Please wait...

Please wait...

TAXOL

Compare TAXOL  to:
Compare
Compare

Generic Name for TAXOL

Paclitaxel 6mg/mL; soln for IV infusion after dilution; contains Cremophor EL (polyoxyethylated castor oil), dehydrated alcohol.

Legal Classification:

Rx

Pharmacological Class for TAXOL

Antimicrotubule agent.

Manufacturer of TAXOL

Bristol-Myers Squibb

Indications for TAXOL

First-line therapy (in combination with cisplatin) and subsequent therapy for advanced carcinoma of the ovary.

Other Indications for TAXOL

Adult dose for TAXOL

See literature. Premedicate with corticosteroids, diphenhydramine, H2 antagonists. Previously untreated ovarian cancer: 175mg/m2 IV over 3 hours + cisplatin every 3 weeks; or 135mg/m2 IV over 24 hours + cisplatin every 3 weeks. Previously treated ovarian cancer: 135mg/m2 or 175mg/m2 IV over 3 hours every 3 weeks. Hepatic impairment or neutropenia: see literature for dose modifications. Do not treat if neutrophil count <1,500cells/mm3 or platelets <100,000cells/mm3.

Children's dosing for TAXOL

Not recommended.

Contraindications for TAXOL

Baseline neutrophil count <1,500cells/mm3.

Warnings/Precautions for TAXOL

Do frequent peripheral blood cell counts. Hepatic dysfunction. Conduction abnormalities: monitor cardiac function. Avoid extravasation. Pregnancy (Cat.D); avoid use. Nursing mothers: not recommended.

Interactions for TAXOL

May potentiate or be potentiated by CYP2C8 or CYP3A4 substrates, inducers and/or inhibitors. Potentiated by cisplatin. May potentiate doxorubicin.

Adverse Reactions for TAXOL

Bone marrow suppression (eg, neutropenia, leukopenia, thrombocytopenia, anemia), inj site reactions, infections, hypotension, bradycardia, hypersensitivity reactions (if severe, do not rechallenge), peripheral neuropathy, myalgia, arthralgia, GI upset, mucositis, alopecia, abnormal ECG, elevated liver enzymes.

How is TAXOL supplied?

Multidose vial (5mL, 16.7mL, 50mL)—1

Related Disease:

Cancer, breast
Cancer, ovarian
Kaposi's sarcoma
Non-small cell lung cancer

Related Resources

Adjuvant Radiochemotherapy Has Lasting Benefit in Gastric Cancer

May 18, 2012

Patients with gastric cancer who undergo resection show survival benefit 10 years later.

Fertility-Related Information Urgently Needed for Female Patients with Cancer

May 18, 2012

Young adult males and females with cancer receive vastly different amounts of fertility-related and fertility preservation information.

STAT3 Mutations ID'd in Rare Lymphoproliferative Disorder

May 18, 2012

Four specific mutations in SH2 domain seen in T-cell large granular lymphocytic leukemia.

Genetic Profiling Improves Prognosis of Uveal Melanoma

May 18, 2012

Gene expression profiling (GEP) and chromosomal analysis show prognostic value in patients with uveal melanoma.

Bisphosphonates Cut Skeletal Morbidity in Multiple Myeloma

May 18, 2012

Zoledronate superior to placebo or etidronate for improving overall survival.

ADRUCIL

Oncology > Colorectal and other GI cancers

Fluorouracil 50mg/mL; soln for IV inj.

PANRETIN

Oncology > Kaposi's sarcoma

Alitretinoin 0.1%; gel.

REVLIMID

Oncology > Leukemias, lymphomas, and other hematologic cancers

Lenalidomide 5mg, 10mg, 15mg, 25mg; caps.

TASIGNA

Oncology > Leukemias, lymphomas, and other hematologic cancers

Nilotinib (as HCl monohydrate) 150mg, 200mg; caps; contains lactose.

THYROGEN

Oncology > Pancreatic, thyroid, and other endocrine cancers

Thyrotropin alfa 1.1mg/vial; lyophilized pwd for IM inj after reconstitution; contains mannitol.

Oncology > Cytoprotective and supportive care agents

Bisphosphonates (eg, Aredia, Zometa) may inhibit the activation of cancer-associated proteins through the suppression of geranyl-geranylation and farnesylation or inhibit ...
more »

'Teachable Moments' for Smoking Cessation in Patients Diagnosed with Cancer Underutilized

Debra Hughes February 16, 2012

Less than one-fifth (18.1%) of healthcare providers reported high levels of confidence in their ability to counsel patients with cancer who smoke to quit smoking, a survey published in The Oncologist online February 14 has found.

Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

May 11, 2012

A look at the following clinical trial: Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

Clinical Study of PM01183 in Patients With Acute Leukemia

May 10, 2012

A look at the following clinical trial: Clinical Study of PM01183 in Patients With Acute Leukemia

Diuretics for Hypertension

December 30, 2011

Hypertension dosing regiment chart for loop, potassium-sparing, and thiazide-like diuretics.

Calcium Channel Blockers Chart

December 30, 2011

Calcium channel blockers (CCB) used to treat hypertension (HTN) including benzothiazepines, dihydropyridines, and diphenylalkylamines.

Beta Blockers

December 30, 2011

Beta blocker pharmacokinetic comparison chart.

Angiotensin-Converting Enzyme (ACE) Inhibitors for Hypertension

December 30, 2011

Angiotensin-Converting Enzyme (ACE) Inhibitors and ACEI Combination Therapy Hypertension Dosing Chart.

Angiotensin II Receptor Blocker (ARB) for Hypertension

December 30, 2011

Angiotensin II Receptor Blockers (ARB) and ARB Hypertension dosing.


© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions